@article{CJCR2612,
author = {Yaying Tan and Bin Wang and Fuguang Liu and Lianmei Zhou and Jun Liu},
title = {RELATION OF MALIGNANT TUMOR TO PROSTACYCLIN AND THROMBOXANE},
journal = {Chinese Journal of Cancer Research},
volume = {7},
number = {1},
year = {2013},
keywords = {},
abstract = {The level of 6-keto-PGF1α and thromboxane B2 (TXB2) in plasma was determined with radioimmunoassay in 58 normal subjects and 92 patients with various cancers (including lung, hepatic, gastric, esophageal and pancreatic carcinoma). The results showed that 6-keto-PGF1α in plasma was 10.21±2.75 Pg/ml, and TXB2 146.03±37.31 Pg/ml in normal individuals, the ratio of 6-keto-PGF1α to TXB2 was 0.07; while in cancer patients 6-keto-PGF1α was 27.5±16.9 Pg/ml and TXB2 315.4±173.4 Pg/ml, the ratio of 6-keto-PGF1α to TXB2 was 0.08. The values of 6-keto-PGF1α and TXB2 in plasma of cancer patients were 2.69 folds and 2.16 folds higher than that of the two groups, respectively. The difference between the two groups was statistically significant (P},
issn = {1993-0631}, url = {https://cjcr.amegroups.org/article/view/2612}
}